Multimodal neuroimaging identifies biomarkers differentiating Alzheimer’s disease, mild cognitive impairment, and late-life depression, suggesting new diagnostic pathways.
These findings highlight distinct EEG spectral patterns in patients with LLD compared to those with AD or MCI, particularly in alpha and high-gamma oscillations. These differences could be potential biomarkers for differentiating these conditions. Combining EEG and fNIRS analyses may further elucidate the neurophysiological mechanisms underlying these disorders.
No takes yet. Share an insight, caveat, or question.
Mei et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: